Mapping the Human Exposome to Uncover the Causes of Breast Cancer.
Vincent Bessonneau, Ruthann A Rudel
https://pubmed.ncbi.nlm.nih.gov/31892107/Actively Recruiting
Led by Instituto Nacional de Cancerologia de Mexico · Updated on 2023-10-19
146
Participants Needed
1
Research Sites
104 weeks
Total Duration
Breast cancer is a leading cause of death among women worldwide, especially in Latin America, where younger women are often diagnosed at advanced stages with aggressive tumor types. Lifestyle factors, including diet, physical activity, and psychological stress, influence the internal and external exposome, which impacts breast cancer development and treatment outcomes. This study evaluates how a multidisciplinary lifestyle intervention might affect the personal exposome and health of young women with breast cancer. The trial compares two groups one receives a hybrid multidisciplinary lifestyle education program delivered through digital tools and face-to-face sessions, while the other receives a personalized hybrid multidisciplinary intervention tailored to clinical evaluations and includes nutritional, psychological, rehabilitation, and mindfulness support. Both groups use digital platforms like apps, workshops, and videos for education and motivational support, with follow-up through various communication methods. Participants will be involved for 18 months, undergoing assessments at baseline and at multiple intervals to measure lifestyle adoption, physical activity, sleep quality, anxiety, depression, mindfulness, body composition, and biochemical markers. Researchers will track adherence through attendance and questionnaires, evaluating quality of life and barriers to lifestyle changes. This comprehensive approach aims to understand how early intervention may improve metabolic control, clinical outcomes, and overall well-being in young breast cancer patients.
CONDITIONS
Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.
M
Marlid Cruz Ramos, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Instituto Nacional de Cancerologia de Mexico
Lead Sponsor
Anahuac University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants will be identified and invited by the program navigator at INCAN, then consented.
Duration - Up to 18 months
Participants receive a hybrid lifestyle intervention consisting of standardized educational sessions and personalized multidisciplinary support including nutrition, psychology, rehabilitation, and mindfulness through face-to-face and remote digital tools.
Regular assessments at baseline, 3, 6, 12, and 18 months; interventions delivered via face-to-face sessions, phone, Zoom, WhatsApp, and digital platforms.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Vincent Bessonneau, Ruthann A Rudel
https://pubmed.ncbi.nlm.nih.gov/31892107/Olivia Febvey-Combes, Elodie Jobard, Adrien Rossary...
https://pubmed.ncbi.nlm.nih.gov/33655799/Amina Amadou, Gabriela Torres-Mejía, Pierre Hainaut...
https://pubmed.ncbi.nlm.nih.gov/25604300/Christina M Dieli-Conwright, Louise Wong, Sarah Waliany...
https://pubmed.ncbi.nlm.nih.gov/27219902/Cynthia Villarreal-Garza, Alejandra Platas, Melina Miaja...
https://pubmed.ncbi.nlm.nih.gov/32020358/Hassan Shaikh, Peter Bradhurst, Li Xin Ma...
https://pubmed.ncbi.nlm.nih.gov/33305350/Andreas Daiber, Swenja Kröller-Schön, Katie Frenis...
https://pubmed.ncbi.nlm.nih.gov/30937979/Julie Richards, Mary Beth Arensberg, Sara Thomas...
https://pubmed.ncbi.nlm.nih.gov/33167544/W Demark-Wahnefried, V Hars, M R Conaway...
https://pubmed.ncbi.nlm.nih.gov/9129482/Cynthia Villarreal-Garza, Alejandra Platas, Melina Miaja...
https://pubmed.ncbi.nlm.nih.gov/32142405/Instituto Nacional de Cancerologia de Mexico
Lead Sponsor
Anahuac University
Collaborating Sponsor